By Sindhu Sundar ( August 14, 2015, 8:09 PM EDT) -- Eli Lilly & Co. told the U.S. Judicial Panel on Multidistrict Litigation Friday to uphold its decision not to consolidate suits over the alleged withdrawal risks of its antidepressant Cymbalta, arguing the plaintiffs' new centralization motion is merely a litigation tactic to bend the drugmaker into settling. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.